Using IVIVC to Optimize Your Drug Formulation After a Failed BA/BE Study
This webinar introduced how IVIVC can be used to get your drug program back on…
CertaraJuly 18, 2018
Overcoming Pitfalls and Challenges with Software Validation
As a quality consultant and quality system subject matter expert in the Life Sciences Industry…
CertaraJune 29, 2018
Apixaban for treatment of venous thromboembolism (VTEtx): Use of MBMA to support Phase 3 dose selection and beyond
Apixaban is an orally available, direct, selective inhibitor of the coagulation factor Xa that reversibly…
CertaraJune 2, 2018
Pharmacokinetic/ Toxicokinetic Services
As your partner for drug development and regulatory strategy, Certara has expanded its services to…
CertaraMay 18, 2018
What’s New in Enterprise 3.4 Q&A
Is there documented guidance on the creation of the sponsor SDTM metadata to be uploaded…
CertaraMay 17, 2018
